| Application no. and date | 09175876.3 (espacenet) (Federated) (European Patent Register), 20091113 | | Patent/reg. no. and date | DK/EP 2324853, 20150826 | | Publication date | 20110525 | | Priority no. and date | | | EP pub. no. and date |
EP 2324853 20110525 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | Sanofi DE2009/199-EP-EPA | | Inventor | Silvestre, Louise, c/o Sanofi-Aventis
Département Brevets
174, Avenue de France
75013 Paris, FR,
Sert-Langeron, Caroline, c/o Sanofi-Aventis
Département Brevets
174, Avenue de France
75013 Paris, FR,
Zhou, Tianyue, Sanofi-Aventis
1041 Route 202-206
Mail Code: BWD-303A
Bridgewater, NJ 08807, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 38/26 (2006.01) , A61K 45/06 (2006.01) | | Title | Lixisenatid som tillægsbehandling til metformin til behandling af diabetes type 2 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
